Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

GLORIA-AF Registry Program - Second and Third Phases
GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients With Atrial Fibrillation (Phase II/III)
Status: Enrolling
Updated:  12/31/1969
Selma Medical Associates, Winchester
mi
from
Winchester, VA
GLORIA-AF Registry Program - Second and Third Phases
GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients With Atrial Fibrillation (Phase II/III)
Status: Enrolling
Updated: 12/31/1969
Selma Medical Associates, Winchester
mi
from
Winchester, VA
Click here to add this to my saved trials
GLORIA-AF Registry Program - Second and Third Phases
GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients With Atrial Fibrillation (Phase II/III)
Status: Enrolling
Updated:  12/31/1969
Sound Medical Research
mi
from
Port Orchard, WA
GLORIA-AF Registry Program - Second and Third Phases
GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients With Atrial Fibrillation (Phase II/III)
Status: Enrolling
Updated: 12/31/1969
Sound Medical Research
mi
from
Port Orchard, WA
Click here to add this to my saved trials
GLORIA-AF Registry Program - Second and Third Phases
GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients With Atrial Fibrillation (Phase II/III)
Status: Enrolling
Updated:  12/31/1969
The Polyclinic
mi
from
Seattle, WA
GLORIA-AF Registry Program - Second and Third Phases
GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients With Atrial Fibrillation (Phase II/III)
Status: Enrolling
Updated: 12/31/1969
The Polyclinic
mi
from
Seattle, WA
Click here to add this to my saved trials
GLORIA-AF Registry Program - Second and Third Phases
GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients With Atrial Fibrillation (Phase II/III)
Status: Enrolling
Updated:  12/31/1969
Franciscan Heart and Vascular Associates
mi
from
Tacoma, WA
GLORIA-AF Registry Program - Second and Third Phases
GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients With Atrial Fibrillation (Phase II/III)
Status: Enrolling
Updated: 12/31/1969
Franciscan Heart and Vascular Associates
mi
from
Tacoma, WA
Click here to add this to my saved trials
GLORIA-AF Registry Program - Second and Third Phases
GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients With Atrial Fibrillation (Phase II/III)
Status: Enrolling
Updated:  12/31/1969
Cardiac and Thoracic Institute of Central Washington
mi
from
Yakima, WA
GLORIA-AF Registry Program - Second and Third Phases
GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients With Atrial Fibrillation (Phase II/III)
Status: Enrolling
Updated: 12/31/1969
Cardiac and Thoracic Institute of Central Washington
mi
from
Yakima, WA
Click here to add this to my saved trials
GLORIA-AF Registry Program - Second and Third Phases
GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients With Atrial Fibrillation (Phase II/III)
Status: Enrolling
Updated:  12/31/1969
CAMC Clinical Trials Center
mi
from
Charleston, WV
GLORIA-AF Registry Program - Second and Third Phases
GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients With Atrial Fibrillation (Phase II/III)
Status: Enrolling
Updated: 12/31/1969
CAMC Clinical Trials Center
mi
from
Charleston, WV
Click here to add this to my saved trials
GLORIA-AF Registry Program - Second and Third Phases
GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients With Atrial Fibrillation (Phase II/III)
Status: Enrolling
Updated:  12/31/1969
University Cardiovascular Services
mi
from
Huntington, WV
GLORIA-AF Registry Program - Second and Third Phases
GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients With Atrial Fibrillation (Phase II/III)
Status: Enrolling
Updated: 12/31/1969
University Cardiovascular Services
mi
from
Huntington, WV
Click here to add this to my saved trials
GLORIA-AF Registry Program - Second and Third Phases
GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients With Atrial Fibrillation (Phase II/III)
Status: Enrolling
Updated:  12/31/1969
St Mary's Medical Center
mi
from
Huntington, WV
GLORIA-AF Registry Program - Second and Third Phases
GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients With Atrial Fibrillation (Phase II/III)
Status: Enrolling
Updated: 12/31/1969
St Mary's Medical Center
mi
from
Huntington, WV
Click here to add this to my saved trials
GLORIA-AF Registry Program - Second and Third Phases
GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients With Atrial Fibrillation (Phase II/III)
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic-Sparta
mi
from
La Crosse, WI
GLORIA-AF Registry Program - Second and Third Phases
GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients With Atrial Fibrillation (Phase II/III)
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic-Sparta
mi
from
La Crosse, WI
Click here to add this to my saved trials
GLORIA-AF Registry Program - Second and Third Phases
GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients With Atrial Fibrillation (Phase II/III)
Status: Enrolling
Updated:  12/31/1969
Karim Bakhtiar MD, SC
mi
from
Milwaukee, WI
GLORIA-AF Registry Program - Second and Third Phases
GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients With Atrial Fibrillation (Phase II/III)
Status: Enrolling
Updated: 12/31/1969
Karim Bakhtiar MD, SC
mi
from
Milwaukee, WI
Click here to add this to my saved trials
GLORIA-AF Registry Program - Second and Third Phases
GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients With Atrial Fibrillation (Phase II/III)
Status: Enrolling
Updated:  12/31/1969
Family Medical Clinic
mi
from
Milwaukee, WI
GLORIA-AF Registry Program - Second and Third Phases
GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients With Atrial Fibrillation (Phase II/III)
Status: Enrolling
Updated: 12/31/1969
Family Medical Clinic
mi
from
Milwaukee, WI
Click here to add this to my saved trials
GLORIA-AF Registry Program - Second and Third Phases
GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients With Atrial Fibrillation (Phase II/III)
Status: Enrolling
Updated:  12/31/1969
Wheaton Franciscan
mi
from
Milwaukee, WI
GLORIA-AF Registry Program - Second and Third Phases
GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients With Atrial Fibrillation (Phase II/III)
Status: Enrolling
Updated: 12/31/1969
Wheaton Franciscan
mi
from
Milwaukee, WI
Click here to add this to my saved trials
GLORIA-AF Registry Program - Second and Third Phases
GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients With Atrial Fibrillation (Phase II/III)
Status: Enrolling
Updated:  12/31/1969
Zablocki VA Medical Center
mi
from
Milwaukee, WI
GLORIA-AF Registry Program - Second and Third Phases
GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients With Atrial Fibrillation (Phase II/III)
Status: Enrolling
Updated: 12/31/1969
Zablocki VA Medical Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
GLORIA-AF Registry Program - Second and Third Phases
GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients With Atrial Fibrillation (Phase II/III)
Status: Enrolling
Updated:  12/31/1969
ProHealth Care Research Institute and Cardiology Associates
mi
from
Waukesha, WI
GLORIA-AF Registry Program - Second and Third Phases
GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients With Atrial Fibrillation (Phase II/III)
Status: Enrolling
Updated: 12/31/1969
ProHealth Care Research Institute and Cardiology Associates
mi
from
Waukesha, WI
Click here to add this to my saved trials
GLORIA-AF Registry Program - Second and Third Phases
GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients With Atrial Fibrillation (Phase II/III)
Status: Enrolling
Updated:  12/31/1969
B&K Medical Research Center
mi
from
Fresno, CA
GLORIA-AF Registry Program - Second and Third Phases
GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients With Atrial Fibrillation (Phase II/III)
Status: Enrolling
Updated: 12/31/1969
B&K Medical Research Center
mi
from
Fresno, CA
Click here to add this to my saved trials
GLORIA-AF Registry Program - Second and Third Phases
GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients With Atrial Fibrillation (Phase II/III)
Status: Enrolling
Updated:  12/31/1969
A & L Clinical Research
mi
from
Miami, FL
GLORIA-AF Registry Program - Second and Third Phases
GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients With Atrial Fibrillation (Phase II/III)
Status: Enrolling
Updated: 12/31/1969
A & L Clinical Research
mi
from
Miami, FL
Click here to add this to my saved trials
GLORIA-AF Registry Program - Second and Third Phases
GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients With Atrial Fibrillation (Phase II/III)
Status: Enrolling
Updated:  12/31/1969
Alternative Solutions Medical Research and Prevention Center
mi
from
Saint Petersburg, FL
GLORIA-AF Registry Program - Second and Third Phases
GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients With Atrial Fibrillation (Phase II/III)
Status: Enrolling
Updated: 12/31/1969
Alternative Solutions Medical Research and Prevention Center
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
GLORIA-AF Registry Program - Second and Third Phases
GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients With Atrial Fibrillation (Phase II/III)
Status: Enrolling
Updated:  12/31/1969
Institute for Heart & Vascular Health
mi
from
Reno, NV
GLORIA-AF Registry Program - Second and Third Phases
GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients With Atrial Fibrillation (Phase II/III)
Status: Enrolling
Updated: 12/31/1969
Institute for Heart & Vascular Health
mi
from
Reno, NV
Click here to add this to my saved trials
GLORIA-AF Registry Program - Second and Third Phases
GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients With Atrial Fibrillation (Phase II/III)
Status: Enrolling
Updated:  12/31/1969
Veterans Affairs Sierra Nevada Health Care System
mi
from
Reno, NV
GLORIA-AF Registry Program - Second and Third Phases
GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients With Atrial Fibrillation (Phase II/III)
Status: Enrolling
Updated: 12/31/1969
Veterans Affairs Sierra Nevada Health Care System
mi
from
Reno, NV
Click here to add this to my saved trials
GLORIA-AF Registry Program - Second and Third Phases
GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients With Atrial Fibrillation (Phase II/III)
Status: Enrolling
Updated:  12/31/1969
Staten Island University Hospital
mi
from
Staten Island, NY
GLORIA-AF Registry Program - Second and Third Phases
GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients With Atrial Fibrillation (Phase II/III)
Status: Enrolling
Updated: 12/31/1969
Staten Island University Hospital
mi
from
Staten Island, NY
Click here to add this to my saved trials
GLORIA-AF Registry Program - Second and Third Phases
GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients With Atrial Fibrillation (Phase II/III)
Status: Enrolling
Updated:  12/31/1969
Consultorios Hematologicos SRL
mi
from
Buenos Aires,
GLORIA-AF Registry Program - Second and Third Phases
GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients With Atrial Fibrillation (Phase II/III)
Status: Enrolling
Updated: 12/31/1969
Consultorios Hematologicos SRL
mi
from
Buenos Aires,
Click here to add this to my saved trials
Sulforaphane-rich Broccoli Sprout Extract for Autism
Sulforaphane-rich Broccoli Sprout Extract for Autism
Status: Enrolling
Updated:  12/31/1969
Lurie Center for Autism, MassGeneral Hospital for Children
mi
from
Lexington, MA
Sulforaphane-rich Broccoli Sprout Extract for Autism
Sulforaphane-rich Broccoli Sprout Extract for Autism
Status: Enrolling
Updated: 12/31/1969
Lurie Center for Autism, MassGeneral Hospital for Children
mi
from
Lexington, MA
Click here to add this to my saved trials
Oral Contraceptives, Insulin Resistance and Cardiovascular Risk Profile in Pre-Menopausal Women
Oral Contraceptives, Insulin Resistance and Cardiovascular Risk Profile in Pre-Menopausal Women
Status: Enrolling
Updated:  12/31/1969
VCU Medical Center
mi
from
Richmond, VA
Oral Contraceptives, Insulin Resistance and Cardiovascular Risk Profile in Pre-Menopausal Women
Oral Contraceptives, Insulin Resistance and Cardiovascular Risk Profile in Pre-Menopausal Women
Status: Enrolling
Updated: 12/31/1969
VCU Medical Center
mi
from
Richmond, VA
Click here to add this to my saved trials
Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma
A Phase II Trial of Sequential SGN-35 Therapy With Adriamycin, Vinblastine, and Dacarbazine (S-AVD) for Older Patients With Untreated Hodgkin Lymphoma
Status: Enrolling
Updated:  12/31/1969
Stanford Univ Med Ctr
mi
from
Stanford, CA
Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma
A Phase II Trial of Sequential SGN-35 Therapy With Adriamycin, Vinblastine, and Dacarbazine (S-AVD) for Older Patients With Untreated Hodgkin Lymphoma
Status: Enrolling
Updated: 12/31/1969
Stanford Univ Med Ctr
mi
from
Stanford, CA
Click here to add this to my saved trials
Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma
A Phase II Trial of Sequential SGN-35 Therapy With Adriamycin, Vinblastine, and Dacarbazine (S-AVD) for Older Patients With Untreated Hodgkin Lymphoma
Status: Enrolling
Updated:  12/31/1969
NorthwesternU
mi
from
Chicago, IL
Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma
A Phase II Trial of Sequential SGN-35 Therapy With Adriamycin, Vinblastine, and Dacarbazine (S-AVD) for Older Patients With Untreated Hodgkin Lymphoma
Status: Enrolling
Updated: 12/31/1969
NorthwesternU
mi
from
Chicago, IL
Click here to add this to my saved trials
Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma
A Phase II Trial of Sequential SGN-35 Therapy With Adriamycin, Vinblastine, and Dacarbazine (S-AVD) for Older Patients With Untreated Hodgkin Lymphoma
Status: Enrolling
Updated:  12/31/1969
University of Chicago
mi
from
Chicago, IL
Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma
A Phase II Trial of Sequential SGN-35 Therapy With Adriamycin, Vinblastine, and Dacarbazine (S-AVD) for Older Patients With Untreated Hodgkin Lymphoma
Status: Enrolling
Updated: 12/31/1969
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma
A Phase II Trial of Sequential SGN-35 Therapy With Adriamycin, Vinblastine, and Dacarbazine (S-AVD) for Older Patients With Untreated Hodgkin Lymphoma
Status: Enrolling
Updated:  12/31/1969
Tufts Medical Center
mi
from
Boston, MA
Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma
A Phase II Trial of Sequential SGN-35 Therapy With Adriamycin, Vinblastine, and Dacarbazine (S-AVD) for Older Patients With Untreated Hodgkin Lymphoma
Status: Enrolling
Updated: 12/31/1969
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma
A Phase II Trial of Sequential SGN-35 Therapy With Adriamycin, Vinblastine, and Dacarbazine (S-AVD) for Older Patients With Untreated Hodgkin Lymphoma
Status: Enrolling
Updated:  12/31/1969
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma
A Phase II Trial of Sequential SGN-35 Therapy With Adriamycin, Vinblastine, and Dacarbazine (S-AVD) for Older Patients With Untreated Hodgkin Lymphoma
Status: Enrolling
Updated: 12/31/1969
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Click here to add this to my saved trials
Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma
A Phase II Trial of Sequential SGN-35 Therapy With Adriamycin, Vinblastine, and Dacarbazine (S-AVD) for Older Patients With Untreated Hodgkin Lymphoma
Status: Enrolling
Updated:  12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma
A Phase II Trial of Sequential SGN-35 Therapy With Adriamycin, Vinblastine, and Dacarbazine (S-AVD) for Older Patients With Untreated Hodgkin Lymphoma
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma
A Phase II Trial of Sequential SGN-35 Therapy With Adriamycin, Vinblastine, and Dacarbazine (S-AVD) for Older Patients With Untreated Hodgkin Lymphoma
Status: Enrolling
Updated:  12/31/1969
M.D. Anderson Cancer Center
mi
from
Houston, TX
Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma
A Phase II Trial of Sequential SGN-35 Therapy With Adriamycin, Vinblastine, and Dacarbazine (S-AVD) for Older Patients With Untreated Hodgkin Lymphoma
Status: Enrolling
Updated: 12/31/1969
M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Effect of Haemodialysis on the Pharmacokinetics of Ezogabine/Retigabine and Its N-acetyl Metabolite
An Open Label, Single-dose, Fixed Sequence, Two Treatment Period Study to Assess the Effect of Haemodialysis on the Pharmacokinetics of Ezogabine/Retigabine and the N-acetyl Metabolite of Ezogabine/Retigabine (NAMR).
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Minneapolis, MN
Effect of Haemodialysis on the Pharmacokinetics of Ezogabine/Retigabine and Its N-acetyl Metabolite
An Open Label, Single-dose, Fixed Sequence, Two Treatment Period Study to Assess the Effect of Haemodialysis on the Pharmacokinetics of Ezogabine/Retigabine and the N-acetyl Metabolite of Ezogabine/Retigabine (NAMR).
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Treatments of Acquired Apraxia of Speech
Treatments of Acquired Apraxia of Speech
Status: Enrolling
Updated:  12/31/1969
VA Salt Lake City Health Care System, Salt Lake City, UT
mi
from
Salt Lake City, UT
Treatments of Acquired Apraxia of Speech
Treatments of Acquired Apraxia of Speech
Status: Enrolling
Updated: 12/31/1969
VA Salt Lake City Health Care System, Salt Lake City, UT
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Phoenix, AZ
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Fresno, CA
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Fresno, CA
Click here to add this to my saved trials
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Oxnard, CA
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Oxnard, CA
Click here to add this to my saved trials
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Sacramento, CA
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Sacramento, CA
Click here to add this to my saved trials
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Bradenton, FL
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Bradenton, FL
Click here to add this to my saved trials
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Ocala, FL
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Ocala, FL
Click here to add this to my saved trials
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Panama City, FL
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Panama City, FL
Click here to add this to my saved trials
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Tampa, FL
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Wellington, FL
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Wellington, FL
Click here to add this to my saved trials
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Louisville, KY
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Hammond, LA
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Hammond, LA
Click here to add this to my saved trials
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Waldorf, MD
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Waldorf, MD
Click here to add this to my saved trials
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Golden Valley, MN
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Golden Valley, MN
Click here to add this to my saved trials
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Springfield, MO
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Springfield, MO
Click here to add this to my saved trials
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Missoula, MT
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Missoula, MT
Click here to add this to my saved trials
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Camden, NJ
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Camden, NJ
Click here to add this to my saved trials
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Greensboro, NC
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Greensboro, NC
Click here to add this to my saved trials
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Canton, OH
eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Canton, OH
Click here to add this to my saved trials